Protective effects of recombinant human growth hormone on cirrhotic rats

World Journal of Gastroenterology

Volumn 10, Issue 19, 2004, Pages 2894-2897

  Chen, Shuang ^a   Wang, Hong Tao ^a   Yang, Bin ^a   Fu, Yu Ru ^a   Ou, Qing Jia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; IODINE 125; MALONALDEHYDE; MESSENGER RNA; PYROGALLOL; SERUM ALBUMIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOACETAMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; HEPATOBILIARY PARAMETERS; HORMONE BINDING; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER PROTECTION; MALE; MORPHOMETRICS; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RAT; RAT STRAIN; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 4644293267     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i19.2894     Document Type: Article

References (40)

1. Strong RW. Liver transplantation: current status and future prospects. J R Coll Surg Edinb 2001; 46: 1-8
2. Dichi JB, Dichi I, Maio R, Correa CR, Angeleli AY, Bicudo MH, Rezende TA, Burini RC. Whole-body protein turnover in malnourished patients with child class B and C cirrhosis on diets low to high in protein energy. Nutrition 2001; 17: 239-242
3. Sobhonslidsuk A, Roongpisuthipong C, Nantiruj K, Kulapongse S, Songchitsomboon S, Sumalnop K, Bussagorn N. Impact of liver cirrhosis on nutritional and immunological status. J Med Assoc Thai 2001; 84: 982-988
4. Maull KI, Turnage B. Trauma in the cirrhotic patient. South Med J 2001; 94: 205-207
5. Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME. Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc 1990; 22: 1560-1563
6. Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int 1997; 10: 369-374
7. Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-794
8. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987; 27: 262-266
9. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000; 69: 1364-1369
10. Carter-Su C, Schwartz J, Smit LS. Molecular mechanism of growth hormone action. Annu Rev Physiol 1996; 58: 187-207
11. Hocquette JF, Postel-Vinay MC, Kayser C, de Hemptinne B, Amar-Costesec A. The human liver growth hormone receptor. Endocrinology 1989; 125: 2167-2174
12. Husman B, Andersson G, Norstedt G, Gustafsson JA. Characterization and subcellular distribution of somatogenic receptor in rat liver. Endocrinology 1985; 116: 2605-2611
13. van Neste L, Husman B, Moller C, Andersson G, Norstedt G. Cellular distribution of somatogenic receptors and insulin-like growth factor-I mRNA in the rat liver. J Endocrinol 1988; 119: 69-74
14. Wong WK, Soo KC, Nambiar R, Tan YS, Yo SL, Tan IK. The effect of recombinant growth hormone on nitrogen balance in malnourished patients after major abdominal surgery. Aust N Z J Surg 1995; 65: 109-113
15. Rodeck B, Kardorff R, Melter M, Ehrich JH. Improvement of growth after growth hormone treatment in children who undergo liver transplantation. J Pediatr Gastroenterol Nutr 2000; 31: 286-290
16. Petersen SR, Holaday NJ, Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994; 36: 726-733
17. Singh KP, Prasad R, Chari PS, Dash RJ. Effect of growth hormone therapy in burn patients on conservative treatment. Burns 1998; 24: 733-738
18. Iglesias P, Diez JJ. Clinical applications of recombinant human growth hormone in adults. Expert Opin Pharmacother 1999; 1: 97-107
19. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995; 221: 649-656
20. Aili Low JF, Barrow RE, Mittendorfer B, Jeschke MG, Chinkes DL, Herndon DN. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns 2001; 27: 447-452
21. Hart DW, Herndon DN, Klein G, Lee SB, Celis M, Mohan S, Chinkes DL, Wolf SE. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 2001; 233: 827-834
22. Vara-Thorbeck R, Guerrero JA, Rosell J, Ruiz-Requena E, Capitan JM. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on post-operative immune function. World J Surg 1993; 17: 530-537
23. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991; 99: 1495-1500
24. Koea JB, Breier BH, Douglas RG, Gluckman PD, Shaw JH. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis. Br J Surg 1996; 83: 196-202
25. Li W, Li J, Xu B, Yin L, Wang L, Gu J, Ren J, Quan Z. Effect of recombinant human growth hormone with total parenteral nutrition on albumin synthesis in patients with peritoneal sepsis. Zhonghua Waike Zazhi 1998; 36: 643-645
26. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996; 125: 873-882
27. Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125: 865-872
28. O'Leary MJ, Ferguson CN, Rennie M, Hinds CJ, Coakley JH, Preedy VR. Effect of growth hormone on muscle and liver protein synthesis in septic rats receiving glutamine-enriched parenteral nutrition. Crit Care Med 2002; 30: 1099-1105
29. Losada F, Garcia-Luna PP, Gomez-Cia T, Garrido M, Pereira JL, Marin F, Astorga R. Effects of human recombinant growth hormone on donor-site healing in burned adults. World J Surg 2002; 26: 2-8
30. Carroll PV, Van den Berghe G. Safety aspects of pharmacological GH therapy in adults. Growth Horm IGF Res 2001; 11: 166-172
31. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792
32. Jeschke MG, Barrow RE, Herndon DN. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med 2000; 28: 1578-1584
33. Raguso CA, Genton L, Kyle U, Pichard C. Management of catabolism in metabolically stressed patients: a literature survey about growth hormone application. Curr Opin Clin Nutr Metab Care 2001; 4: 313-320
34. Wilmore DW. Postoperative protein sparing. World J Surg 1999; 23: 545-552
35. Zhao J, van Tol HT, Taverne MA, van der Weijden GC, Bevers MM, van den Hurk R. The effect of growth hormone on rat pre-antral follicles in vitro. Zygote 2000; 8: 275-283
36. Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T, Seeff LB, Sorell M, Tamburro C, Zetterman R. VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 1986; 43: 213-218
37. Moller S, Becker U, Gronbaek M, Juul A, Winkler K, Skakkebaek NE. Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis. J Hepatol 1994; 21: 710-717
38. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin like growth factor-1, and insulin like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21: 680-688
39. Chang TC, Lin JJ, Yu SC, Chang TJ. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology 1990; 11: 123-126
40. Shen XY, Holt RI, Miell JP, Justice S, Portmann B, Postel-Vinay MC, Ross RJ. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors. J Clin Endocrinol Metab 1998; 83: 2532-2538